Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
On standardization of controls in lifespan studies.
Spiridonova O, Kriukov D, Nemirovich-Danchenko N, Peshkin L. Spiridonova O, et al. Aging (Albany NY). 2024 Feb 27;16(4):3047-3055. doi: 10.18632/aging.205604. Epub 2024 Feb 27. Aging (Albany NY). 2024. PMID: 38421245 Free PMC article.
Open Genes-a new comprehensive database of human genes associated with aging and longevity.
Rafikova E, Nemirovich-Danchenko N, Ogmen A, Parfenenkova A, Velikanova A, Tikhonov S, Peshkin L, Rafikov K, Spiridonova O, Belova Y, Glinin T, Egorova A, Batin M. Rafikova E, et al. Among authors: spiridonova o. Nucleic Acids Res. 2024 Jan 5;52(D1):D950-D962. doi: 10.1093/nar/gkad712. Nucleic Acids Res. 2024. PMID: 37665017 Free PMC article.
On standardization of controls in lifespan studies.
Spiridonova O, Kriukov D, Nemirovich-Danchenko N, Peshkin L. Spiridonova O, et al. bioRxiv [Preprint]. 2023 Aug 18:2023.08.17.552381. doi: 10.1101/2023.08.17.552381. bioRxiv. 2023. PMID: 37645987 Free PMC article. Updated. Preprint.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
A massive white-dwarf merger product before final collapse.
Gvaramadze VV, Gräfener G, Langer N, Maryeva OV, Kniazev AY, Moskvitin AS, Spiridonova OI. Gvaramadze VV, et al. Among authors: spiridonova oi. Nature. 2019 May;569(7758):684-687. doi: 10.1038/s41586-019-1216-1. Epub 2019 May 20. Nature. 2019. PMID: 31110332